The treatment, which involves genetically modified immune cells, will be offered to patients with advanced non-Hodgkin lymphoma.
Laurie McGinley, Washington Post U.S.
Wed, 10/18/2017 - 3:51pm
The treatment, which involves genetically modified immune cells, will be offered to patients with advanced non-Hodgkin lymphoma.